A new head-to-head study reveals tirzepatide achieves 47% more weight loss than semaglutide in people with obesity but ...

Tirzepatide (Zepbound) led to more weight loss than semaglutide (Wegovy) in a clinical trial funded by Eli Lilly. Participants who received tirzepatide also had greater improvements in metabolic risk ...

In study after study, injected GLP-1 weight loss medications appear to work better on average for women than they do for men.

Despite early success, however, Novo Nordisk has fallen behind in the GLP-1RA race, overtaken by Eli Lilly and its GLP-1RA ...

In a head-to-head comparison between the two drugs, patients taking tirzepatide underwent 47% more relative weight loss than those taking semaglutide. It was a major win for Eli Lilly, giving the ...

It's a look at these medicines that are used to treat obesity and it's a head-to-head comparison ... The two medications are tirzepatide and semaglutide. The semaglutide is what's known as ...

KATIE Price has sparked concern after she looked slimmer than ever in her latest Instagram post. The star, 47, has been ...

Providers of compounded obesity drugs are finding—for now—a new way into the booming market by tweaking formulations.

Experts already know that losing weight reduces the risk of cancer, but now they think weight-loss jabs may have a role ...

Madrigal Pharmaceuticals beat Q1 sales estimates with Rezdiffra, and catalysts like EU approval and pipeline plans add upside ...